Article Details
Retrieved on: 2022-08-26 09:02:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Several other brokerages have also issued reports on AZN. Barclays lifted their price target on shares of AstraZeneca from £120 ($145.00) to £125 ($ ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here